Simfibrate: Difference between revisions
m (Protected "Simfibrate": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
(3 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| IUPAC_name = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate | | IUPAC_name = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate | ||
Line 25: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
{{CMG}} | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
'''Synonyms and related keywords:''' 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin | |||
==Overview== | ==Overview== | ||
'''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use. | '''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use. | ||
==References== | |||
{{reflist|2}} | |||
{{Lipid modifying agents}} | {{Lipid modifying agents}} | ||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Fibrates]] | [[Category:Fibrates]] | ||
Latest revision as of 16:47, 27 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C23H26Cl2O6 |
Molar mass | 469.354 g/mol |
WikiDoc Resources for Simfibrate |
Articles |
---|
Most recent articles on Simfibrate |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Simfibrate at Clinical Trials.gov Clinical Trials on Simfibrate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Simfibrate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Simfibrate Discussion groups on Simfibrate Patient Handouts on Simfibrate Directions to Hospitals Treating Simfibrate Risk calculators and risk factors for Simfibrate
|
Healthcare Provider Resources |
Causes & Risk Factors for Simfibrate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and related keywords: 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin
Overview
Simfibrate is a fibrate. As May 20th, 2008 there is no approved drug form for human use.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Fibrates